← Leaderboards
Dara Torgerson
University Of California, San Francisco
$3,937,806
Attributed
$9,781,523
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,781,523 · 6
By mechanism
R01$9,337,717 · 5
R21$443,806 · 1
Top collaborators
- Philip L. Ballard6 shared
- Lyle G Best4 shared
- Esther Erdei4 shared
- Aaron Hamvas2 shared
- Paul E Moore2 shared
- Danish Saleheen2 shared
- Ryan D. Hernandez1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jeffrey D Wall$5,705,975
Others in their field
Other Emerging Leaders on “Genetic”
- Leonard Freedman · Leidos Biomedical Research, Inc.$89,060,933
- Ted Ross · University Of Georgia$68,763,143
- Scott Topper · Broad Institute, Inc.$64,989,588
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Dale Sandler · Social And Scientific Systems, Inc.$43,209,852
Research focus
GeneticCohortInfantRespiratoryGenomicsBiologicalChildhoodResponseBiological MarkersLung DiseasesPregnancyVariantGenome Wide Association StudyLungPathway InteractionsSamplingBronchopulmonary DysplasiaProgramsSeveritiesPrematurePremature InfantHigh RiskPhysiological ProcessesPrevent
Grant awards (15)
Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD)$1,906,644
R01 · FY2025 · HL
Genetic ancestry effects on molecular and complex traits in TOPMed$804,982
R01 · FY2025 · HL
Factors Influencing Pediatric Asthma into Adulthood (FIPA2)$543,377
R01 · FY2025 · MD
Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD)$2,070,206
R01 · FY2024 · HL
Factors Influencing Pediatric Asthma into Adulthood (FIPA2)$525,404
R01 · FY2024 · MD
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2024 · HL
Factors Influencing Pediatric Asthma into Adulthood (FIPA2)$120,454
R01 · FY2024 · MD
Factors Influencing Pediatric Asthma into Adulthood (FIPA2)$551,650
R01 · FY2023 · MD
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2023 · HL
Leveraging consanguinity and homozygosity to identify novel recessive variants$600,000
R01 · FY2022 · HG · contact PI
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2022 · HL
Leveraging consanguinity and homozygosity to identify novel recessive variants$600,000
R01 · FY2021 · HG · contact PI
Integrative metabolomics of bronchopulmonary dysplasia in extremely low gestational age infants$403,750
R01 · FY2021 · HL
The Urinary Metabolome and Bronchopulmonary Dysplasia in Premature Infants$241,891
R21 · FY2020 · HD
The Urinary Metabolome and Bronchopulmonary Dysplasia in Premature Infants$201,915
R21 · FY2019 · HD